CitationCount for Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome (Frontiers in Immunology, (2021), 12, (633297), 10.3389/fimmu.2021.633297)